Antigingivitis/Antiplaque Combination With Other Actives Excluded In ANPR
This article was originally published in The Rose Sheet
Executive Summary
FDA's advance notice of proposed rulemaking on OTC antigingivitis/antiplaque products excludes the combination of antigingivitis/antiplaque ingredients with other oral health care ingredients. The 1notice was published in the May 29 Federal Register